Search Results

Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.

• Authors : De Las Cuevas C; Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, University of La Laguna, Canary Islands, Spain; Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, San Cristóbal de La Laguna, Spain. Electronic address: .

• Source: Schizophrenia research [Schizophr Res] 2023 Dec 07. Date of Electronic Publication: 2023 Dec 07.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database.

• Authors : de Filippis R; Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy. Electronic address: .; De Las Cuevas C

• Source: Schizophrenia research [Schizophr Res] 2023 Nov 18. Date of Electronic Publication: 2023 Nov 18.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.

• Authors : Sagud M; School of Medicine, University of Zagreb, Zagreb, Croatia; University Hospital Centre Zagreb, Zagreb, Croatia. Electronic address: .

• Source: Schizophrenia research [Schizophr Res] 2023 Sep 30. Date of Electronic Publication: 2023 Sep 30.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

A brief history of clozapine in China with a look forward.

• Authors : Ruan CJ; The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China. Electronic address: .

• Source: Schizophrenia research [Schizophr Res] 2023 May 24. Date of Electronic Publication: 2023 May 24.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing.

• Authors : de Leon J; Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA.; Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain.

• Source: Psychiatry investigation [Psychiatry Investig] 2023 Mar; Vol. 20 (3), pp. 183-195. Date of Electronic Publication: 2023 Feb 28.Publisher: Korean Neuropsychiatric Association Country of Publication: Korea (South) NLM ID: 101242994 Publication Model: Print-Electronic Cited Medium:

Record details

Should we routinely add CRP to clozapine titrations? - Learning from three cases.

• Authors : Shelton C; Eastern State Hospital, and the Department of Psychiatry, University of Kentucky, Lexington, KY, USA.; Ruan CJ

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced

• Source: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology [Neuropsychopharmacol Hung] 2022 Publisher: Neuroline Country of Publication: Hungary NLM ID: 100961631 Publication Model: Print Cited Medium: Print ISSN: 1419-8711 (Print)

Record details

Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.

• Authors : De Las Cuevas C; Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine and Instituto Universitario de Neurociencia (IUNE) University of La Laguna, Canary Islands, Spain.; Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced

• Source: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2022 Nov; Vol. 18 (11), pp. 715-727. Date of Electronic Publication: 2022 Dec 28.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series.

• Authors : Ertuğrul A; Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: .; Anıl Yağcıoğlu AE

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced ; Myocarditis*/Myocarditis*/Myocarditis*/diagnosis

• Source: Revista de psiquiatria y salud mental [Rev Psiquiatr Salud Ment (Engl Ed)] 2022 Oct-Dec; Vol. 15 (4), pp. 281-286.Publisher: Elsevier España Country of Publication: Spain NLM ID: 101744920 Publication Model: Print Cited Medium: Internet ISSN: 2173-5050

Record details

Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.

• Authors : De Las Cuevas C; Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, Instituto Universitario de Neurociencias (IUNE), University of La Laguna, Canary Islands, Spain.; Sanz EJ

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced ; Myocarditis*/Myocarditis*/Myocarditis*/diagnosis

• Source: Revista de psiquiatria y salud mental [Rev Psiquiatr Salud Ment (Engl Ed)] 2022 Oct-Dec; Vol. 15 (4), pp. 238-250.Publisher: Elsevier España Country of Publication: Spain NLM ID: 101744920 Publication Model: Print Cited Medium: Internet ISSN: 2173-5050

Record details

Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases.

• Authors : Koenig M; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; McCollum B

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced

• Source: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology [Neuropsychopharmacol Hung] 2022 Publisher: Neuroline Country of Publication: Hungary NLM ID: 100961631 Publication Model: Print Cited Medium: Print ISSN: 1419-8711 (Print)

Record details